Value Sense
CNC
Centene Corporation (CNC)
Last Price$58.60.7%
Market Cap$29.1B
LTM Net Debt to Free Cash Flow
(3.8x)
5Y avg
0.2x
Medical - Healthcare Plans industry median
(1.3x)
Stock quality & Intrinsic value
5/10
23.0% undervalued
CNC
is 2,301.3% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Centene Corporation Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
CNC
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Net Debt to Free Cash Flow
(2.4x)
(1.1x)
(0.7x)
(1.4x)
(0.8x)
(2.5x)
(1.9x)
(2.3x)
(1.5x)
(0.8x)
(1.4x)
0.1x
0.1x
1.1x
2.0x
0.9x
1.3x
0.7x
(0.1x)
(5.6x)
CNC
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CNC and see if it's the right time to invest.
Dive in

Centene Corporation (CNC) Net Debt to Free Cash Flow comparison analysis

General

LTM Net Debt to Free Cash Flow

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Centene Corporation logo
Centene CorporationCNC
(3.8x)
5.9%
27.4%
2.0%
Median Peer Set
(1.3x)
8.7%
(11.9%)
1.1%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
63.9x
27.2%
(4.8%)
(8.1%)
CVS Health Corporation logo
CVS Health CorporationCVS
11.4x
4.2%
(43.6%)
1.2%
Cigna Corporation logo
Cigna CorporationCI
2.7x
8.4%
(18.9%)
2.6%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
(0.1x)
(51.9%)
86.2%
(103.4%)
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
(1.2x)
8.9%
(35.7%)
3.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
(1.4x)
3.2%
(0.0%)
3.4%
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(1.7x)
(41.5%)
(31.3%)
(10.5%)
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
(1.9x)
56.5%
N/A
0.3%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
(2.8x)
19.3%
9.2%
2.9%
Humana Inc. logo
Humana Inc.HUM
(3.6x)
10.7%
(50.1%)
1.0%

CNC key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
1,505.9
50.4%
2,279.0
51.3%
2,919.3
28.1%
3,364.5
15.3%
4,102.9
21.9%
4,448.3
8.4%
5,340.6
20.1%
8,667.6
62.3%
10,863.3
25.3%
16,560.0
52.4%
22,760.0
37.4%
40,607.0
78.4%
48,382.0
19.1%
60,116.0
24.3%
74,639.0
24.2%
111,115.0
48.9%
125,982.0
13.4%
144,547.0
14.7%
153,999.0
6.5%
163,071.0
5.9%
Cost of Goods Sold (COGS)1,232.81,880.52,385.92,697.33,450.23,743.44,402.97,962.19,654.814,656.020,014.035,063.042,581.051,695.065,796.095,899.0111,783.0127,891.0122,458.0128,436.0
Gross Profit
% margin
273.1
18.1%
398.5
17.5%
533.4
18.3%
667.3
19.8%
652.7
15.9%
704.9
15.8%
937.7
17.6%
705.5
8.1%
1,208.6
11.1%
1,904.0
11.5%
2,746.0
12.1%
5,544.0
13.7%
5,801.0
12.0%
8,421.0
14.0%
8,843.0
11.8%
15,216.0
13.7%
14,199.0
11.3%
16,656.0
11.5%
31,541.0
20.5%
34,635.0
21.2%
Operating Expenses193.9427.4479.3535.7514.5547.8747.4704.6931.11,440.02,041.04,284.04,602.06,963.06,791.012,062.010,936.013,020.028,611.031,460.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)193.9346.3399.7444.7514.5547.8587.0704.6931.11,440.02,041.04,137.04,446.06,752.06,533.011,343.010,166.011,589.012,563.012,400.0
Operating Income
% margin
79.2
5.3%
(28.9)
(1.3%)
54.1
1.9%
131.6
3.9%
138.1
3.4%
157.1
3.5%
190.3
3.6%
(27.1)
(0.3%)
277.4
2.6%
464.0
2.8%
705.0
3.1%
1,260.0
3.1%
1,199.0
2.5%
1,458.0
2.4%
1,781.0
2.4%
3,082.0
2.8%
3,263.0
2.6%
3,636.0
2.5%
2,930.0
1.9%
3,175.0
1.9%
Interest Income0.00.00.00.00.00.00.00.00.00.00.00.00.00.0443.0376.0665.0665.00.00.0
Interest Expense4.010.615.616.716.318.020.320.527.035.043.0217.0255.0343.0412.0728.0665.0665.0725.0702.0
Pre-tax Income85.9(21.7)63.6136.6137.5154.3174.9(11.6)268.9457.0697.01,157.01,134.01,368.01,782.02,773.01,813.01,962.03,598.04,257.0
Income Tax
% effective tax rate
30.2
35.2%
22.0
(101.5%)
22.4
35.1%
52.4
38.4%
48.8
35.5%
59.9
38.8%
66.5
38.0%
(0.3)
2.8%
107.1
39.8%
196.0
42.9%
339.0
48.6%
599.0
51.8%
326.0
28.7%
474.0
34.6%
473.0
26.5%
979.0
35.3%
477.0
26.3%
760.0
38.7%
899.0
25.0%
963.0
22.6%
Net Income
% margin
55.6
3.7%
(43.6)
(1.9%)
73.4
2.5%
83.5
2.5%
83.7
2.0%
94.8
2.1%
111.2
2.1%
1.9
0.0%
165.1
1.5%
271.0
1.6%
355.0
1.6%
562.0
1.4%
828.0
1.7%
900.0
1.5%
1,321.0
1.8%
1,808.0
1.6%
1,347.0
1.1%
1,202.0
0.8%
2,702.0
1.8%
3,305.0
2.0%
EPS0.33(0.25)0.420.480.490.490.560.010.761.171.491.762.402.313.193.172.312.094.976.33
Diluted EPS0.31(0.25)0.410.470.470.470.530.010.741.131.441.722.352.263.143.122.282.074.956.31
EBITDA
% margin
102.9
6.8%
9.6
0.4%
81.9
2.8%
167.0
5.0%
182.1
4.4%
224.3
5.0%
248.7
4.7%
66.8
0.8%
354.6
3.3%
581.0
3.5%
851.0
3.7%
1,652.0
4.1%
1,750.0
3.6%
2,206.0
3.7%
2,837.0
3.8%
4,760.0
4.3%
3,954.0
3.1%
4,058.0
2.8%
5,616.0
3.6%
6,200.0
3.8%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Centene Corporation's Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is (3.8x), based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Net Debt to Free Cash Flow for Centene Corporation have been 0.2x over the past three years, and 0.2x over the past five years.

2) Is Centene Corporation's Net Debt to Free Cash Flow Good?

As of today, Centene Corporation's Net Debt to Free Cash Flow is (3.8x), which is lower than industry median of (1.3x). It indicates that Centene Corporation's Net Debt to Free Cash Flow is Good.

3) How does Centene Corporation's Net Debt to Free Cash Flow compare to its peers?

As of today, Centene Corporation's Net Debt to Free Cash Flow is (3.8x), which is lower than peer median of (1.3x). The list of peers includes ALHC, CVS, CI, BHG, UNH, ELV, CLOV, OSCR, MOH, HUM.